These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4420440)

  • 1. The fate of soluble fibrin monomer in relation to intravascular fibrin formation and degradation in rabbits.
    Gurewich V; Wetmore R; Nowak A; Lipinski B
    Blood; 1974 Nov; 44(5):723-33. PubMed ID: 4420440
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of heparin and dipyridamole on the deposition of fibrin-like material in rabbits infused with soluble fibrin monomer or fibrinogen.
    Lipinski B; Gurewich V; Nowak A; Wetmore R
    Thromb Res; 1974 Sep; 5(3):343-58. PubMed ID: 4439374
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of intravascular fibrin deposition by dipyridamole in experimental animals.
    Gurewich V; Lipinski B; Wetmore R
    Blood; 1975 Apr; 45(4):569-75. PubMed ID: 1090312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential degradation of soluble fibrin monomers in streptokinase-activated plasma.
    Konttinen YP; Lalla ML; Turunen O
    Thromb Diath Haemorrh; 1973 Nov; 30(2):403-13. PubMed ID: 4543990
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Mosesson MW
    Thromb Diath Haemorrh Suppl; 1973; 56():75-90. PubMed ID: 4218377
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 7. Disseminated intravascular coagulation in the early phase of experimental traumatic and haemorrhagic shock.
    Avikainen V; Eklund B
    Ann Chir Gynaecol Fenn; 1974; 63(3):217-25. PubMed ID: 4412844
    [No Abstract]   [Full Text] [Related]  

  • 8. The abscence of intravascular clotting in rat anaphylaxis.
    Fésüs L; Csongor J
    Experientia; 1976 Nov; 32(11):1477-8. PubMed ID: 992005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The laboratory diagnosis of venous thromboembolic disease by measurement of fibrinogen-fibrin degradation products and fibrin monomer.
    Gurewich V; Hume M; Patrick M
    Chest; 1973 Nov; 64(5):585-90. PubMed ID: 4750329
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of granulocytes in the activation of intravascular coagulation and the precipitation of soluble fibrin by endotoxin.
    Müller-Berghaus G; Eckhardt T
    Blood; 1975 May; 45(5):631-41. PubMed ID: 1091310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble fibrin monomer complexes and fibrinolytic activity in kidney during the generalized Shwartzman reaction in rabbit.
    Szczepanski M; Lucer C
    Thromb Res; 1975 May; 6(5):399-408. PubMed ID: 1135791
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products.
    Niewiarowski S; Gurewich V
    J Lab Clin Med; 1971 Apr; 77(4):665-76. PubMed ID: 4928905
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo behaviour of homologous urea-soluble 131I-fibrin and 125I-fibrinogen in rabbits: the effect of fibrinolysis inhibition.
    Müller-Berghaus G; Mahn I; Köveker G; Maul FD
    Br J Haematol; 1976 May; 33(1):61-79. PubMed ID: 1268091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy.
    Hedner U
    Scand J Clin Lab Invest; 1973 Oct; 32(2):175-82. PubMed ID: 4588514
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrinogen and fibrin degradation products].
    Fujimaki M; Ikematsu S; Kato M
    Rinsho Byori; 1973 Jan; 21(1):31-6. PubMed ID: 4267650
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of N-acetylcysteine on fibrin deposition in the rat lung due to intravascular coagulation.
    Wegener T; Wallin R; Saldeen T
    Ups J Med Sci; 1986; 91(1):45-52. PubMed ID: 3716022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of dextran 40 upon thrombin-induced fibrin deposition in rat lungs.
    Diffang C; Rammer L; Saldeen T
    Ups J Med Sci; 1976; 81(1):23-7. PubMed ID: 1273996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-induced disseminated intravascular coagulation in the dog. I: Demonstration of microthrombi in lung.
    Jastrzebski J; Arnot RN; Hilgard P; Sykes MK
    Br J Anaesth; 1975 Jun; 47(6):654-7. PubMed ID: 1148085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.